| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 15.450 | 5.643 | 15.887 | 5.143 | 2.548 |
| Total Income - EUR | - | - | - | - | - | 15.450 | 5.643 | 15.972 | 5.143 | 2.570 |
| Total Expenses - EUR | - | - | - | - | - | 58 | 11.207 | 22.075 | 9.437 | 14.011 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 15.392 | -5.564 | -6.103 | -4.293 | -11.442 |
| Net Profit/Loss - EUR | - | - | - | - | - | 14.948 | -5.620 | -6.262 | -4.345 | -11.467 |
| Employees | - | - | - | - | - | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Nci Prodprim S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 15.257 | 9.322 | 14.295 | 17.433 | 6.452 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 154 | 154 | 153 |
| Cash | - | - | - | - | - | 15.257 | 9.322 | 14.141 | 17.280 | 6.299 |
| Shareholders Funds | - | - | - | - | - | 14.989 | 9.036 | 2.802 | -1.551 | -13.009 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 268 | 285 | 11.493 | 18.984 | 19.461 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4332 - 4332" | |||||||||
| CAEN Financial Year |
4332
|
|||||||||
Comments - Nci Prodprim S.r.l.